A Toddler, Three Missing Glipizide Tablets, and a Normal Glucose
A 3-year-old boy weighing 14 kg is brought to a community emergency department after his mother found him playing with his grandmother's glipizide 5 mg tablets; three tablets are missing. He was well at home. On arrival, 90 minutes after the likely ingestion, he is sleepy but rousable, and a point-of-care glucose is 48 mg/dL. He receives 10 mL/kg of D10W and the glucose rises to 112 mg/dL. He is now playful and eating crackers. It is 4 hours since ingestion, and the closest pediatric intensive care unit is 2 hours away by road. His parents ask whether he can go home.
1. How do you counsel the parents about discharge right now, and what determines how long this child must be monitored?
Read the worked answer
He cannot go home yet. The single most important teaching point is that sulfonylureas cause delayed, recurrent, and prolonged hypoglycemia, and a normal glucose 4 hours after ingestion predicts nothing.
Why: glipizide closes pancreatic beta-cell potassium channels, causing insulin release that is independent of the blood glucose. The drug has a duration of action of 12–24 hours, and a toddler has limited glycogen stores, so a dose that would barely affect an adult can produce recurrent hypoglycemia after the initial dextrose bolus has been metabolized - typically within 1–3 hours. The ingested dose here is roughly 1.1 mg/kg, well above the threshold at which pediatric hypoglycemia is expected.
Disposition: admit for at least 24 hours of glucose monitoring, with a lower threshold in practice - many centers observe 24 hours from ingestion and extend it if any hypoglycemia occurs or if the child needs a dextrose infusion. If this hospital cannot guarantee hourly point-of-care glucose with immediate access to IV dextrose and a clinician at the bedside, transfer him to the pediatric center before the next dip, not after it. Do not send him home with instructions to "watch for sleepiness," because sleepiness is the sign of neuroglycopenia, not an early warning of it.
2. Describe your dextrose strategy and your indications, dosing, and monitoring for octreotide. What if octreotide is unavailable or he keeps dropping?
Read the worked answer
Dextrose: use D10W 5 mL/kg boluses for symptomatic or neuroglycopenic hypoglycemia, followed by a continuous infusion at 1.5 times maintenance, and titrate upward. Avoid D50W boluses in a small child because of hyperosmolar injury and rebound; avoid relying on oral carbohydrate alone in a child with a long-acting sulfonylurea. Recheck glucose 15 minutes after every bolus and hourly once stable.
Octreotide is the specific adjunct: it suppresses insulin secretion and reduces the dextrose requirement. Give 1–1.5 µg/kg subcutaneously or intravenously every 6 hours, or a continuous infusion of about 4–5 µg/kg/day. Use it for recurrent hypoglycemia despite dextrose, for a large ingestion, or prophylactically in a symptomatic child. Monitor glucose (it can overshoot to hyperglycemia), heart rate (bradycardia), abdominal pain, and nausea; it may prolong the QT interval, so obtain an ECG.
If octreotide is unavailable, maintain a dextrose infusion and frequent feeds and arrange transfer to a center that stocks it. If hypoglycemia persists despite octreotide plus maximal dextrose, escalate to a pediatric intensive care unit for central access, higher-concentration dextrose, and consideration of continuous infusion octreotide or glucagon - recognizing that glucagon may itself provoke insulin release and is a weak tool in sulfonylurea poisoning.
3. What else must be done before this child leaves the hospital, beyond glucose control?
Read the worked answer
Look beyond the single drug. Ask what else was in the grandmother's pill organizer and consider co-ingestants - opioids, beta-blockers, and other antihyperglycemics are common in older relatives' homes and change the observation plan. A targeted history and an ECG are cheap.
Safeguarding: a 3-year-old accessing an adult's medication is a preventable event, and recurrence is common. Provide concrete counseling: medications stored up and locked, never in a purse or bedside drawer, child-resistant containers closed properly, and visitors' bags out of reach. Emphasize that one tablet can seriously injure a toddler - families often assume a single pill is harmless. Give the poison center number and record it in the discharge instructions.
Documentation: the time and estimated dose of ingestion, serial glucose values with times, dextrose and octreotide doses, the observation period, and the counseling provided. Note who was present for the counseling. If the history is inconsistent with the findings, or there have been previous ingestions, involve the appropriate safeguarding team rather than treating it as an isolated accident.
Follow-up: confirm the primary care visit, and consider a prescription safety review for the grandmother if she is the child's caregiver.